Gajendra K Katara Selected Research

Vacuolar Proton-Translocating ATPases (V-Type ATPase)

9/2018	Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells.
1/2018	Mammary epithelium-specific inactivation of V-ATPase reduces stiffness of extracellular matrix and enhances metastasis of breast cancer.
11/2016	Cancer derived peptide of vacuolar ATPase 'a2' isoform promotes neutrophil migration by autocrine secretion of IL-8.
1/2016	Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells.
10/2015	The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells.
10/2015	Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression.
2/2015	Vacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gajendra K Katara Research Topics

Disease

14	Neoplasms (Cancer) 10/2020 - 02/2015
6	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2015
5	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 02/2015
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
4	Inflammation (Inflammations) 01/2018 - 03/2015
3	Premature Obstetric Labor (Premature Labor) 01/2018 - 10/2015
2	Carcinoma (Carcinomatosis) 01/2016 - 02/2015
1	Carcinogenesis 01/2020
1	Infections 01/2018
1	Premature Birth (Birth, Premature) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Foreign Bodies (Foreign Body) 01/2016
1	Triple Negative Breast Neoplasms 10/2015

Drug/Important Bio-Agent (IBA)

10	Protein Isoforms (Isoforms)IBA 10/2020 - 02/2015
10	Adenosine Triphosphatases (ATPase)IBA 10/2020 - 02/2015
7	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 09/2018 - 02/2015
3	Proton Pumps (Proton Pump)IBA 10/2020 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2015
3	Notch ReceptorsIBA 11/2016 - 10/2015
2	CytokinesIBA 01/2020 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2015
2	Peptides (Polypeptides)IBA 01/2020 - 11/2016
2	Interleukin-22 (IL-22)IBA 01/2020 - 01/2018
2	PlatinumIBA 01/2019 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2016
2	LipopolysaccharidesIBA 01/2018 - 01/2016
2	delta proteinIBA 01/2016 - 10/2015
2	Jagged-1 ProteinIBA 01/2016 - 10/2015
2	LigandsIBA 01/2016 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	Caspase 3 (Caspase-3)IBA 10/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2020
1	Protons (Proton)IBA 10/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	InterleukinsIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	BenzopyransIBA 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 11/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Mifepristone (RU 486)FDA Link 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Platinum Compounds (Compounds, Platinum)IBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	Interleukin-10 (Interleukin 10)IBA 10/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2015
1	Peptidoglycan (Murein)IBA 10/2015
1	Cytidine Monophosphate (CMP)IBA 10/2015
1	Poly I-CIBA 10/2015
1	Toll-Like Receptor AgonistsIBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	CortactinIBA 02/2015
1	Actins (F Actin)IBA 02/2015
1	Peptide Hydrolases (Proteases)FDA Link 02/2015
1	Matrix Metalloproteinases (MMPs)IBA 02/2015

Therapy/Procedure

6	Therapeutics 01/2020 - 10/2015
1	Immunotherapy 10/2020
1	Treatment Delay 10/2020
1	Subcutaneous Injections 01/2016
1	Transplantation 01/2016